166 related articles for article (PubMed ID: 15787967)
1. Water-soluble prodrugs of cyclosporine A with tailored conversion rates.
Hamel AR; Hubler F; Mutter M
J Pept Res; 2005 Mar; 65(3):364-74. PubMed ID: 15787967
[TBL] [Abstract][Full Text] [Related]
2. Development of water-soluble prodrugs of the HIV-1 protease inhibitor KNI-727: importance of the conversion time for higher gastrointestinal absorption of prodrugs based on spontaneous chemical cleavage.
Sohma Y; Hayashi Y; Ito T; Matsumoto H; Kimura T; Kiso Y
J Med Chem; 2003 Sep; 46(19):4124-35. PubMed ID: 12954064
[TBL] [Abstract][Full Text] [Related]
3. Biological conversion of a water-soluble prodrug of cyclosporine A.
Lallemand F; Varesio E; Felt-Baeyens O; Bossy L; Hopfgartner G; Gurny R
Eur J Pharm Biopharm; 2007 Sep; 67(2):555-61. PubMed ID: 17475453
[TBL] [Abstract][Full Text] [Related]
4. Conversion of cyclosporine A prodrugs in human tears vs rabbits tears.
Lallemand F; Felt-Baeyens O; Rudaz S; Hamel AR; Hubler F; Wenger R; Mutter M; Besseghir K; Gurny R
Eur J Pharm Biopharm; 2005 Jan; 59(1):51-6. PubMed ID: 15567301
[TBL] [Abstract][Full Text] [Related]
5. A water-soluble prodrug of cyclosporine A for ocular application: a stability study.
Lallemand F; Perottet P; Felt-Baeyens O; Kloeti W; Philippoz F; Marfurt J; Besseghir K; Gurny R
Eur J Pharm Sci; 2005 Sep; 26(1):124-9. PubMed ID: 15978789
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporin A prodrugs: design, synthesis and biophysical properties.
Hamel AR; Hubler F; Carrupt A; Wenger RM; Mutter M
J Pept Res; 2004 Feb; 63(2):147-54. PubMed ID: 15009536
[TBL] [Abstract][Full Text] [Related]
7. Preparation, characterization and in vivo conversion of new water-soluble sulfenamide prodrugs of carbamazepine.
Hemenway JN; Nti-Addae K; Guarino VR; Stella VJ
Bioorg Med Chem Lett; 2007 Dec; 17(23):6629-32. PubMed ID: 17928225
[TBL] [Abstract][Full Text] [Related]
8. In vivo characterisation of a novel water-soluble Cyclosporine A prodrug for the treatment of dry eye disease.
Rodriguez-Aller M; Kaufmann B; Guillarme D; Stella C; Furrer P; Rudaz S; El Zaoui I; Valamanesh F; Di Tommaso C; Behar-Cohen F; Veuthey JL; Gurny R
Eur J Pharm Biopharm; 2012 Apr; 80(3):544-52. PubMed ID: 22155591
[TBL] [Abstract][Full Text] [Related]
9. Water soluble cyclosporine monomethoxy poly(ethyleneglycol) conjugates as potential prodrugs.
Cho H; Chung Y
Arch Pharm Res; 2004 Jun; 27(6):662-9. PubMed ID: 15283470
[TBL] [Abstract][Full Text] [Related]
10. A novel water-soluble cyclosporine A prodrug: ocular tolerance and in vivo kinetics.
Lallemand F; Furrer P; Felt-Baeyens O; Gex-Fabry M; Dumont JM; Besseghir K; Gurny R
Int J Pharm; 2005 May; 295(1-2):7-14. PubMed ID: 15847987
[TBL] [Abstract][Full Text] [Related]
11. No auxiliary, no byproduct strategy for water-soluble prodrugs of taxoids: scope and limitation of O-N intramolecular acyl and acyloxy migration reactions.
Skwarczynski M; Sohma Y; Noguchi M; Kimura M; Hayashi Y; Hamada Y; Kimura T; Kiso Y
J Med Chem; 2005 Apr; 48(7):2655-66. PubMed ID: 15801856
[TBL] [Abstract][Full Text] [Related]
12. O-N intramolecular acyl migration reaction in the development of prodrugs and the synthesis of difficult sequence-containing bioactive peptides.
Sohma Y; Hayashi Y; Skwarczynski M; Hamada Y; Sasaki M; Kimura T; Kiso Y
Biopolymers; 2004; 76(4):344-56. PubMed ID: 15386265
[TBL] [Abstract][Full Text] [Related]
13. Novel prodrug approach for tertiary amines: synthesis and preliminary evaluation of N-phosphonooxymethyl prodrugs.
Krise JP; Zygmunt J; Georg GI; Stella VJ
J Med Chem; 1999 Aug; 42(16):3094-100. PubMed ID: 10447953
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and pharmacological evaluation of the aqueous prodrugs of desmethyl anethole trithione with hepatoprotective activity.
Chen P; Luo Y; Hai L; Qian S; Wu Y
Eur J Med Chem; 2010 Jul; 45(7):3005-10. PubMed ID: 20392547
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, enzymatic hydrolysis and physico-chemical properties of N-substituted 4-(aminomethyl)benzoate diester prodrugs of ganciclovir.
Jensen E; Bundgaard H
Acta Pharm Nord; 1991; 3(4):243-7. PubMed ID: 1781915
[TBL] [Abstract][Full Text] [Related]
16. Water-soluble prodrugs of the human immunodeficiency virus protease inhibitors lopinavir and ritonavir.
DeGoey DA; Grampovnik DJ; Flosi WJ; Marsh KC; Wang XC; Klein LL; McDaniel KF; Liu Y; Long MA; Kati WM; Molla A; Kempf DJ
J Med Chem; 2009 May; 52(9):2964-70. PubMed ID: 19348416
[TBL] [Abstract][Full Text] [Related]
17. A novel approach of water-soluble paclitaxel prodrug with no auxiliary and no byproduct: design and synthesis of isotaxel.
Hayashi Y; Skwarczynski M; Hamada Y; Sohma Y; Kimura T; Kiso Y
J Med Chem; 2003 Aug; 46(18):3782-4. PubMed ID: 12930140
[TBL] [Abstract][Full Text] [Related]
18. Development of novel water-soluble photocleavable protective group and its application for design of photoresponsive paclitaxel prodrugs.
Noguchi M; Skwarczynski M; Prakash H; Hirota S; Kimura T; Hayashi Y; Kiso Y
Bioorg Med Chem; 2008 May; 16(10):5389-97. PubMed ID: 18440235
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and in vitro evaluation of novel water-soluble prodrugs of buparvaquone.
Mäntylä A; Rautio J; Nevalainen T; Keski-Rahkonen P; Vepsälainen J; Järvinen T
Eur J Pharm Sci; 2004 Oct; 23(2):151-8. PubMed ID: 15451003
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and anti-cancer efficacy of rapid hydrolysed water-soluble paclitaxel pro-drugs.
Ryu BY; Sohn JS; Hess M; Choi SK; Choi JK; Jo BW
J Biomater Sci Polym Ed; 2008; 19(3):311-24. PubMed ID: 18325233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]